AGXT2 and cardiovascular disorder: Collectively, we hypothesize that the loss of AGXT2 function induces elevated SBP and DBP through the dysregulation of the NOS/ADMA pathway, which means that we can estimate the risk of cardiovascular diseases by detecting AGXT2 SNPs.